{"id":27270,"date":"2024-02-15T10:57:21","date_gmt":"2024-02-15T08:57:21","guid":{"rendered":"https:\/\/vilkaviskiovsb.lt\/?p=27270"},"modified":"2024-02-15T10:57:21","modified_gmt":"2024-02-15T08:57:21","slug":"pacientams-kompensuojami-nauji-vaistiniai-preparatai-ir-medicinos-pagalbos-priemones","status":"publish","type":"post","link":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/2024\/02\/15\/pacientams-kompensuojami-nauji-vaistiniai-preparatai-ir-medicinos-pagalbos-priemones\/","title":{"rendered":"Pacientams kompensuojami nauji vaistiniai preparatai ir medicinos pagalbos priemon\u0117s"},"content":{"rendered":"<div class=\"info-block__wrap clearfix\">\n<p><strong>Vaistini\u0173 preparat\u0173 ir medicinos pagalbos priemoni\u0173 kompensavimo komisijos sprendimas nuo 2024 m. vasario \u012f Kompensuojam\u0173j\u0173 vaist\u0173 s\u0105ra\u0161\u0105 \u012ftraukti visus a\u0161tuonis Rezerviniame s\u0105ra\u0161e buvusius vaistinius preparatus pad\u0117s u\u017etikrinti pacientams \u0161iuolaiki\u0161k\u0105 ir efektyv\u0173 onkologini\u0173, plau\u010di\u0173 ir \u0161irdies lig\u0173 gydym\u0105. Naujiems vaistams kompensuoti papildomai skirta 13,5 mln. eur\u0173 Privalomojo sveikatos draudimo fondo (PSDF) biud\u017eeto l\u0117\u0161\u0173.<\/strong><\/p>\n<p>\u201ePSDF biud\u017eetui kasmet augant, \u012f kompensavimo sistem\u0105 \u012ftraukiama vis daugiau papildom\u0105 naud\u0105 pacient\u0173 sveikatai sukurian\u010di\u0173 vaist\u0173, kurie padeda kovoti su sunkiausiomis ligomis. A\u0161tuoni vaistiniai preparatai, kurie i\u0161 Rezervinio s\u0105ra\u0161o perkeliami \u012f kompensuojam\u0173j\u0173 vaist\u0173 s\u0105ra\u0161\u0105, leis dar efektyviau gydyti onkologines, plau\u010di\u0173 ir \u0161irdies ligas\u201c, \u2013 teigia sveikatos apsaugos viceministras Aurimas Pe\u010dkauskas.<\/p>\n<p>Gydytojai jau dabar gali i\u0161ra\u0161yti pacientams penkis naujus kompensuojamuosius vaistus:<\/p>\n<ul>\n<li>apalutamid\u0105 \u2013 prostatos v\u0117\u017eiui gydyti;<\/li>\n<li>osimertinib\u0105 \u2013 plau\u010di\u0173 v\u0117\u017eiui gydyti;<\/li>\n<li>nintedanib\u0105 \u2013 kitoms l\u0117tin\u0117ms fibrozin\u0117ms progresuojan\u010dio fenotipo intersticin\u0117ms plau\u010di\u0173 ligoms gydyti;<\/li>\n<li>atezolizumab\u0105 \u2013 plau\u010di\u0173 v\u0117\u017eiui gydyti;<\/li>\n<li>dapagliflozin\u0105 \u2013 \u0161irdies nepakankamumui gydyti.<\/li>\n<\/ul>\n<p>Artimiausiu metu, kai vaist\u0173 gamintojai pasira\u0161ys sutartis su Valstybine ligoni\u0173 kasa d\u0117l PSDF i\u0161laid\u0173 \u0161iems vaistiniams preparatams valdymo, \u012f kompensavimo sistem\u0105 bus \u012ftraukti dar trys nauji vaistai:<\/p>\n<ul>\n<li>cemiplimabas, skirtas odos plok\u0161\u010di\u0173j\u0173 l\u0105steli\u0173 karcinomai gydyti;<\/li>\n<li>olaparibas, skirtas epiteliniam kiau\u0161id\u017ei\u0173, kiau\u0161intaki\u0173, pirminiam pilvapl\u0117v\u0117s v\u0117\u017eiui gydyti;<\/li>\n<li>pembrolizumabas, skirtas galvos ir kaklo plok\u0161\u010dial\u0105stelinei karcinomai gydyti.<\/li>\n<\/ul>\n<p>Nuo vasario 1 d. PSDF biud\u017eeto l\u0117\u0161omis taip pat yra kompensuojamos dvi medicinos pagalbos priemon\u0117s: kiekvienam pacientui asmeni\u0161kai pritaikomas chirurginis instrumentas, skirtas kaul\u0173 onkologin\u0117mis ligomis sergan\u010di\u0173 pacient\u0173 operacijoms atlikti, ir chirurgini\u0173 si\u016bl\u0173 sukabinimo ir kirpimo \u012frenginys su titaniniais si\u016bl\u0173 fiksatoriais, skirtais chirurginiam \u0161irdies vo\u017etuv\u0173 pa\u017eeidim\u0173 gydymui.<\/p>\n<p>Taip pat gestaciniu diabetu sergan\u010dioms n\u0117\u0161\u010diosioms nuo vasario 1 d. prad\u0117ta kompensuoti viena adata insulino \u0161virk\u0161tikliui per par\u0105 ir padidintas diagnostini\u0173 gliukoz\u0117s juosteli\u0173 gliukozei nustatyti kiekis iki 150 juosteli\u0173 per pirmuosius 3 m\u0117nesius po gestacinio diabeto diagnoz\u0117s nustatymo, v\u0117liau yra kompensuojama iki 50 juosteli\u0173 per 3 m\u0117nesius.<\/p>\n<p>2024 m. PSDF biud\u017eete vaistams, medicinos pagalbos priemon\u0117ms ir medicinos priemoni\u0173 nuomai i\u0161 viso numatyta 634 mln. eur\u0173.<\/p>\n<p><a href=\"https:\/\/sam.lrv.lt\/lt\/kontaktai-ziniasklaidai\" target=\"_blank\" rel=\"noopener\"><em>SAM Komunikacijos skyrius<\/em><\/a><\/p>\n<p><strong>Ligoni\u0173 kasos kvie\u010dia:<\/strong><\/p>\n<ul>\n<li><em>Skaityti svarbiausias naujienas Facebook:\u00a0<a title=\"https:\/\/goo.gl\/ml8sqj\" href=\"https:\/\/goo.gl\/ML8SqJ\" target=\"_blank\" rel=\"noreferrer noopener\" aria-label=\"Saitas https:\/\/goo.gl\/ML8SqJ\">https:\/\/goo.gl\/ML8SqJ<\/a><\/em><\/li>\n<li><em>Sekti m\u016bs\u0173 \u012fstaigos veikl\u0105 LinkedIn:\u00a0<a title=\"https:\/\/tinyurl.com\/2sxfh66j\" href=\"https:\/\/tinyurl.com\/2sxfh66j\" target=\"_blank\" rel=\"noreferrer noopener\" aria-label=\"Saitas https:\/\/tinyurl.com\/2sxfh66j\u00a0\">https:\/\/tinyurl.com\/2sxfh66j\u00a0<\/a><\/em><\/li>\n<li><em>Pamatyti naujausias nuotraukas Instagram:\u00a0<a title=\"https:\/\/goo.gl\/txvpxr\" href=\"https:\/\/goo.gl\/tXvpXr\" target=\"_blank\" rel=\"noreferrer noopener\" aria-label=\"Saitas https:\/\/goo.gl\/tXvpXr\">https:\/\/goo.gl\/tXvpXr<\/a><\/em><\/li>\n<li><em>\u017di\u016br\u0117ti\u00a0vaizdo \u012fra\u0161us Youtube:\u00a0<a title=\"https:\/\/goo.gl\/bpbep2\" href=\"https:\/\/goo.gl\/BPBep2\" target=\"_blank\" rel=\"noreferrer noopener\" aria-label=\"Saitas https:\/\/goo.gl\/BPBep2\">https:\/\/goo.gl\/BPBep2<\/a><\/em><\/li>\n<li><em>Sekti i\u0161skirtinius infografikus Flickr:\u00a0<a title=\"https:\/\/goo.gl\/bgtzg2\" href=\"https:\/\/goo.gl\/bGtZg2\" target=\"_blank\" rel=\"noreferrer noopener\" aria-label=\"Saitas https:\/\/goo.gl\/bGtZg2\">https:\/\/goo.gl\/bGtZg2<\/a><\/em><\/li>\n<li><em>R\u016bpimus klausimus pateikti\u00a0<a title=\"mailto:patlk@vlk.lt\" href=\"mailto:patlk@vlk.lt\" target=\"_blank\" rel=\"noreferrer noopener\" aria-label=\"Saitas info@vlk.lt\">info@vlk.lt<\/a>\u00a0arba +370 5 232 2222.<\/em><\/li>\n<\/ul>\n<p>VLK informacija<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Vaistini\u0173 preparat\u0173 ir medicinos pagalbos priemoni\u0173 kompensavimo komisijos sprendimas nuo 2024 m. vasario \u012f Kompensuojam\u0173j\u0173 vaist\u0173 s\u0105ra\u0161\u0105 \u012ftraukti visus a\u0161tuonis Rezerviniame s\u0105ra\u0161e buvusius vaistinius preparatus pad\u0117s u\u017etikrinti pacientams \u0161iuolaiki\u0161k\u0105 ir efektyv\u0173 onkologini\u0173, plau\u010di\u0173 ir \u0161irdies lig\u0173 gydym\u0105. Naujiems vaistams kompensuoti papildomai skirta 13,5 mln. eur\u0173 Privalomojo sveikatos draudimo fondo (PSDF) biud\u017eeto l\u0117\u0161\u0173. \u201ePSDF biud\u017eetui kasmet&hellip;<\/p>\n","protected":false},"author":3,"featured_media":27271,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[6],"tags":[],"class_list":["post-27270","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-naujienos","category-6","description-off"],"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p7kWFe-75Q","jetpack_featured_media_url":"https:\/\/vilkaviskiovsb.lt\/wp-content\/uploads\/2024\/02\/EEpNKQeVy5V2.jpg","post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts\/27270","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/comments?post=27270"}],"version-history":[{"count":1,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts\/27270\/revisions"}],"predecessor-version":[{"id":27272,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts\/27270\/revisions\/27272"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/media\/27271"}],"wp:attachment":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/media?parent=27270"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/categories?post=27270"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/tags?post=27270"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}